MDV Launches New Financing Programme for Biotechnology

(From L-R) YBhg Datuk Siti Hadzar Mohd Ismail, MDV Advisor & Director; Encik Md Zubir Ansori Yahaya, Managing Director / Chief Executive Officer of MDV; YB Dato’ Ahmad Husni Mohamad Hanadzlah, Deputy Minister of Finance I and the children who were involved in the launch (From L-R) Razlan, Rosana, Aina and Dania.

KUALA LUMPUR, Tuesday, 6 May 2008: Malaysia Debt Ventures Berhad (“MDV”), a wholly-owned subsidiary of the Minister of Finance, Inc. incorporated to be a financier and development facilitator of Information and Communication Technology (ICT) and high-growth sectors announced its new Financing Programme for Biotechnology to support the emerging biotechnology industry in Malaysia today.

Officiated by the Deputy Minister of Finance, YB Dato’ Haji Ahmad Husni Mohamad Hanadzlah, the launch introduced MDV project financing facilities exclusively for biotechnology companies growing beyond the pre-commercialisation stage, encompassing the funding of the sector’s Equipment & Infrastructure, Working Capital, and received Projects/Contracts.

Encik Md Zubir Ansori Yahaya, Managing Director and Chief Executive Officer of MDV said that the launch of the programme was timely in accordance to the growing socio-economic and economic value of biotechnology research.

“Biotechnology is not merely a key driver for innovation and knowledge creation but an impetus for change. Its true value lies in its capacity to alleviate the biggest challenges faced in the world today, be it curing ravaging diseases, solving world hunger or creating sustainable energy. Unlike other financing institutions, MDV is in a unique position to drive the industry forward and it is only appropriate that we act on it now,” he said.

With the new loan facility, eligible companies will be able to receive revolving project loans of between RM2 million to RM120 million with financing margins of up to 85 per cent of the contract value and loan tenure periods of up to 120 months.

Financing rates will be between six per cent to eight per cent per annum for the duration of the loan period, calculated on a daily basis and no penalties will be imposed for early repayment.

MDV employs a loan process model made simple for borrowers; taking no more than 45 working days from the date of submission of completed documents. The company also prefers director’s guarantee, assignment of contract proceeds and debentures instead of the conventional hard asset collateral as preferred by financial institutions.

“At MDV, we go beyond financial accessibility and provide value-add advisory services to customers. While we want to partner our customers at every stage of development, our philosophy is to ensure that they maintain full ownership of their businesses,” added Zubir.

MDV’s new Financing Programme for Biotechnology is in tandem with the government’s National Biotechnology Policy to utilise the country’s abundance of wealth in bio-diversity and providing a conducive environment for biotech-driven businesses to flourish.

MDV为生化科技领域推出新财务融资

吉隆坡2008年5月6 日（星期二）: 专为科技资讯（ICT）及高档领域提供融资和开发的财政部机构独资子公司马Malaysia Debt Ventures Berhad，MDV）今天宣布为马来西亚的生化科技领域推出新的财务融资计划。

今天，由副财政部长拿督哈芝阿末胡斯尼莫哈末哈纳兹拉（YB Dato ' Haji Ahmad Husni Mohamad Hanadzlah）所主持的推介仪式介绍了三项专为前商业化阶段的贷款选择给生化科技公司，包括有关领域的仪器和基设、运作资金及所获得的工程/合约。

大马投创董事经理兼首席执行员因仄莫哈末祖比尔安苏里耶哈也（Encik Md Zubir Ansori Yahaya ）说，根据社会经济的成长及生化研发的经济价值，这项推介是实时的。

他说：“生化科技不仅是创新和知识创作的关键，也是改变的推动力。它的真实价值在于缓和当今世界所面对的最大挑战，不论是治疗破坏性疾病、解决世界饥饿或创造承受能量。不同于其它金融机，MDV具有驱使行业前进的独特地位，现在是行动的时候。”

新贷款便利让合格的公司可获得200万到1亿令吉的运作金贷款，或等于85％的合同价格及长达120个月的摊还期。

贷款期间内的融资年利率介于6至12％之间，每天计算。不过，提前还清贷款则不会被罚款。
MDV所使用的贷款处理模式使借贷程序简单化。 通常，在文件呈上不超过45个工作天就会获得批准。公司只需要董事的保证书、工程收入委托和公司债务取代一般金融公司所需要的不动产抵押。

他续说：“在MDV，我们除了为顾客提供融资之外，也提供增值咨询服务。在我们要成为顾客每一个发展阶段伙伴的同时，我们的哲理是保证他们完全拥有属于自己企业。”

MDV为生化科技提供新融资计划是为了响应政府的国家生化科技政策，即应用国家丰富生物多元化提供一个驱使生化科技繁荣的有利环境。